Facebook
Twitter
Telegram
Report an ErrorMerrimack Pharmaceuticals Cash Flow 2011-2024 | MACK
Annual Cash Flow Merrimack Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.52 M | -1.74 M | -218 K | -4.62 M | -31.4 M | -65.6 M | -126 M | -170 M | -105 M | -34.8 M | - | - | - |
Depreciation & Amortization |
- | - | - | - | 2.23 M | 4.07 M | 5.22 M | 4.9 M | 3.25 M | 2.44 M | 2.59 M | 3.66 M | 4.6 M |
Accounts Payables |
74 K | 188 K | 120 K | 123 K | 271 K | 1.03 M | 2.89 M | 2.69 M | 5.05 M | 2.51 M | 1.89 M | 283 K | - |
Accounts Receivables |
- | - | - | - | - | - | 100 K | 275 K | 6.48 M | 3.31 M | 5.86 M | 9.27 M | - |
Total Inventories |
- | - | - | - | - | - | - | - | 3.72 M | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Merrimack Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.31 M | - | - | - | -356 K | - | -1.56 M | - | -354 K | - | 137 K | - | -437 K | - | -2.85 M | -2.98 M | -1 M | - | -28.7 M | -25.5 M | -13.7 M | - | -46.7 M | -33.6 M | -17.3 M | - | -101 M | -75.4 M | -10.2 M | - | -139 M | -104 M | -53.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.23 M | 2.23 M | 1.22 M | - | 3.21 M | 2.26 M | 1.24 M | - | 2.81 M | 2.06 M | 1.18 M | - | 4.18 M | 2.33 M | 1.2 M | - | 4.32 M | 2.09 M | 1.05 M | - | 2.81 M | 2.24 M | 886 K | - | 1.93 M | 1.32 M | 700 K | - | 2.94 M | 2.26 M | 1.2 M | - | 4.03 M | 2.67 M | 1.32 M |
Accounts Payables |
168 K | 74 K | 111 K | 80 K | 89 K | 188 K | 67 K | - | 177 K | 120 K | 104 K | 173 K | 108 K | 123 K | 123 K | 123 K | 123 K | 271 K | 271 K | 271 K | 271 K | 1.03 M | 1.03 M | 1.03 M | 1.03 M | 2.89 M | 2.89 M | 2.89 M | 2.89 M | 2.69 M | 2.69 M | 2.69 M | 2.69 M | 3.85 M | 5.05 M | 5.05 M | 5.05 M | 2.51 M | 2.51 M | 2.51 M | 2.51 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | 283 K | 283 K | 283 K | 283 K | 4.66 M | 4.66 M | 4.66 M | 4.66 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100 K | 190 K | 43 K | 43 K | 275 K | 275 K | 275 K | 275 K | 11 K | 6.48 M | 6.48 M | 6.48 M | 3.31 M | 3.31 M | 3.31 M | 3.31 M | 5.86 M | 5.86 M | 5.86 M | 5.86 M | 9.27 M | 9.27 M | 9.27 M | 9.27 M | 7.43 M | 7.43 M | 7.43 M | 7.43 M |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.6 M | 14.8 M | 12.3 M | 8.08 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency